CurrentRheuma coverage · page 6 of 16
Arthritis & Rheumatology
Latest from Arthritis & Rheumatology
Arthritis Rheumatol
Arthritis Rheumatol
The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical Outcomes
Cohort studySpondyloarthritis & PsA
Arthritis Rheumatol
Arthritis Rheumatol
Arthritis Rheumatol
A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Randomized controlled trialLupus & APS
Arthritis Rheumatol
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
Cohort studyAutoinflammatory & rare
Arthritis Rheumatol
Arthritis Rheumatol
Arthritis Rheumatol
Arthritis Rheumatol
Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome
Cross-sectional studyPediatric
Arthritis Rheumatol
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
Secondary analysisVasculitis & PMR
Arthritis Rheumatol
Arthritis Rheumatol
Clinical Significance of Gut Microbiota Community Types for Long‐Term Response to Fecal Microbiota Transplantation in Patients With Psoriatic Arthritis
Secondary analysisSpondyloarthritis & PsA
Arthritis Rheumatol
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin‐Associated Periodic Syndrome
Mechanistic studyAutoinflammatory & rare
Arthritis Rheumatol
Arthritis Rheumatol
Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis
Secondary analysisSystemic sclerosis
Arthritis Rheumatol
Arthritis Rheumatol
Distinct Cancer Risk Profiles in Patients With Systemic Sclerosis With Autoantibody Stratification
Cohort studySystemic sclerosis
Arthritis Rheumatol
Arthritis Rheumatol
Arthritis Rheumatol
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation: An Early Remission Induction Study
Cohort studySpondyloarthritis & PsA
Arthritis Rheumatol
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
Guideline or statementLupus & APS
Arthritis Rheumatol
Arthritis Rheumatol
Arthritis Rheumatol
Longitudinal Autoantibody and Proteomic Signatures of Disease Progression in Systemic Sclerosis
Cohort studySystemic sclerosis
Arthritis Rheumatol
Arthritis Rheumatol
Arthritis Rheumatol
Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis
Randomized controlled trialSpondyloarthritis & PsA
Arthritis Rheumatol
Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis
Cross-sectional studyPediatric
Arthritis Rheumatol
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden
Cross-sectional studyAutoinflammatory & rare
Arthritis Rheumatol
Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease
Cohort studySpondyloarthritis & PsA
Arthritis Rheumatol
Genetics of Childhood‐Onset Systemic Lupus Erythematosus
Cohort studyLupus & APS
Arthritis Rheumatol
Linking Skin and Joint Inflammation in Psoriatic Arthritis through Shared CD8 + T Cell Clones
Mechanistic studySpondyloarthritis & PsA
Arthritis Rheumatol
Arthritis Rheumatol
Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double‐Blind, Phase 3 Trial in China
Randomized controlled trialGout & crystals
Arthritis Rheumatol
Arthritis Rheumatol
Systemic Autoimmune Rheumatic Disease Risk: Association With Long‐Term Exposure to Fine Particulate Matter
Cohort studyAcross diseases
Arthritis Rheumatol
Arthritis Rheumatol
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis
Randomized controlled trialVasculitis & PMR
Arthritis Rheumatol
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel
Guideline or statementAutoinflammatory & rare